文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

口腔癌免疫反应的文献计量分析

A bibliometric analysis of immune response in oral cancer.

作者信息

Zhang Rongrong, Guo Runying, Xin Yuqi, Jiang Qingkun, Qiu Jiaxuan

机构信息

Department of Stomatology, The First Affiliated Hospital of Nanchang University, Nanchang, China.

Key Laboratory of Oral Science, Nanchang First Affiliated Hospital, Nanchang, Jiangxi, China.

出版信息

Discov Oncol. 2025 Feb 10;16(1):146. doi: 10.1007/s12672-025-01912-w.


DOI:10.1007/s12672-025-01912-w
PMID:39928177
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11811321/
Abstract

BACKGROUND: Oral squamous cell carcinoma (OSCC), a type of oral cancer, has a high mortality rate and unfavorable outcomes. Its tumor microenvironment (TME) is intricate and adaptable, with research frequently focusing on the immune reaction. Scholars are exploring ways to enhance survival by bolstering the immune response within the TME. However, a comprehensive trend analysis is lacking. Bibliometric analysis can address this by visualizing research patterns. This study aimed to map these trends in OSCC immunology from 2003 to 2023. METHODS: An immunology-focused search on OSCC was executed within the Web of Science Core Collection, spanning 2003 to 2023. Despite its narrow focus, the search offers a telling glimpse of current researches in this domain. Bibliometric analysis was performed using VOSviewer, Citespace, Scimago Graphica, and R software. RESULTS: From 2003 to 2023, the field has published 805 publications, predominantly from China and the United States. The most valuable contributing author is Friedman Jay, topping co-citation counts. The journal Oral Oncology is the leading journal with the highest publication volume. An analysis of keyword bursts indicated that research into nivolumab and chemotherapy is a prevalent area of interest within the clinical community. These findings suggest that neoadjuvant immunotherapy represents a promising avenue for future therapeutic development. CONCLUSIONS: This study presented a summary of the current trends and research frontiers in the field of immunological aspects of OSCC. This summary can serve as a valuable reference and a source of new insights into this area of research.

摘要

背景:口腔鳞状细胞癌(OSCC)是一种口腔癌,死亡率高且预后不佳。其肿瘤微环境(TME)复杂且具有适应性,研究常聚焦于免疫反应。学者们正在探索通过增强TME内的免疫反应来提高生存率的方法。然而,缺乏全面的趋势分析。文献计量分析可以通过可视化研究模式来解决这一问题。本研究旨在描绘2003年至2023年OSCC免疫学的这些趋势。 方法:在科学网核心合集中对2003年至2023年的OSCC进行了以免疫为重点的检索。尽管检索范围较窄,但能让我们对该领域当前的研究有一个有价值的了解。使用VOSviewer、Citespace、Scimago Graphica和R软件进行文献计量分析。 结果:2003年至2023年,该领域共发表了805篇论文,主要来自中国和美国。最具贡献价值的作者是杰伊·弗里德曼,共被引次数最多。《口腔肿瘤学》杂志是发表量最高的领先期刊。关键词爆发分析表明,纳武单抗和化疗的研究是临床领域普遍关注的热点。这些发现表明,新辅助免疫疗法是未来治疗发展的一个有前景的途径。 结论:本研究总结了OSCC免疫学领域的当前趋势和研究前沿。这一总结可为该研究领域提供有价值的参考和新的见解来源。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14ea/11811321/7c4fe0fd5d92/12672_2025_1912_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14ea/11811321/24231d4f10b2/12672_2025_1912_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14ea/11811321/c24902a1161d/12672_2025_1912_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14ea/11811321/39ed0f13d587/12672_2025_1912_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14ea/11811321/8b63a313a0a5/12672_2025_1912_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14ea/11811321/6bcf0722ca62/12672_2025_1912_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14ea/11811321/616b974b8291/12672_2025_1912_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14ea/11811321/7c4fe0fd5d92/12672_2025_1912_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14ea/11811321/24231d4f10b2/12672_2025_1912_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14ea/11811321/c24902a1161d/12672_2025_1912_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14ea/11811321/39ed0f13d587/12672_2025_1912_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14ea/11811321/8b63a313a0a5/12672_2025_1912_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14ea/11811321/6bcf0722ca62/12672_2025_1912_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14ea/11811321/616b974b8291/12672_2025_1912_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14ea/11811321/7c4fe0fd5d92/12672_2025_1912_Fig7_HTML.jpg

相似文献

[1]
A bibliometric analysis of immune response in oral cancer.

Discov Oncol. 2025-2-10

[2]
Current perspectives and trends of CD39-CD73-eAdo/A2aR research in tumor microenvironment: a bibliometric analysis.

Front Immunol. 2024

[3]
Bibliometric analysis of laryngeal cancer treatment literature (2003-2023).

Heliyon. 2024-12-16

[4]
A bibliometric insight into neoadjuvant chemotherapy in bladder cancer: trends, collaborations, and future avenues.

Front Immunol. 2024

[5]
Bibliometric study of immunotherapy for hepatocellular carcinoma.

Front Immunol. 2023

[6]
Research Trends in the Application of Artificial Intelligence in Oncology: A Bibliometric and Network Visualization Study.

Front Biosci (Landmark Ed). 2022-8-31

[7]
Global research trends and focus on immunotherapy for endometrial cancer: a comprehensive bibliometric insight and visualization analysis (2012-2024).

Front Immunol. 2025-4-8

[8]
Research hotspots and frontiers in the tumor microenvironment of colorectal cancer: a bibliometric study from 2014 to 2024.

Front Oncol. 2025-2-5

[9]
Immune regulation and the tumor microenvironment in anti-PD-1/PDL-1 and anti-CTLA-4 therapies for cancer immune evasion: A bibliometric analysis.

Hum Vaccin Immunother. 2024-12-31

[10]
Global trends in tumor-associated neutrophil research: a bibliometric and visual analysis.

Front Immunol. 2025-3-14

本文引用的文献

[1]
Advances in CAR-T cell therapy for hematologic and solid malignancies: latest updates from 2024 ESMO Congress.

J Hematol Oncol. 2024-12-5

[2]
Immunotherapy and Radiotherapy for Older Patients with Locally Advanced Non-Metastatic Non-Small-Cell Lung Cancer Who Are Not Candidates for or Decline Surgery and Chemotherapy: A Practical Proposal by the International Geriatric Radiotherapy Group.

Cancers (Basel). 2024-9-9

[3]
Novel vaccination strategies based on optimal stimulation of CD4 T helper cells for the treatment of oral squamous cell carcinoma.

Front Immunol. 2024

[4]
Complete tumor resection reverses neutrophilia-associated suppression of systemic anti-tumor immunity.

Oral Oncol. 2024-3

[5]
The dynamic role of immune checkpoint molecules in diagnosis, prognosis, and treatment of head and neck cancers.

Biomed Pharmacother. 2024-2

[6]
Nivolumab for Patients With High-Risk Oral Leukoplakia: A Nonrandomized Controlled Trial.

JAMA Oncol. 2024-1-1

[7]
Margin distance in oral tongue cancer surgery: A systematic review of survival and recurrence outcomes.

Oral Oncol. 2023-12

[8]
Bibliometric analysis of rheumatic immune related adverse events associated with immune checkpoint inhibitors.

Front Immunol. 2023

[9]
Neoadjuvant chemotherapy enhances tumor-specific T cell immunity in patients with HPV-associated oropharyngeal cancer.

Head Neck. 2023-9

[10]
Dynamics and specificities of T cells in cancer immunotherapy.

Nat Rev Cancer. 2023-5

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索